We are live on ! Find out more
BNR

Burning Rock Biotech
BNR

42 hedge funds and large institutions have $49.5M invested in Burning Rock Biotech in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 20 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.15% less ownership

Funds ownership: 2.65% → 2.5% (-0.15%)

6% less capital invested

Capital invested by funds: $52.5M → $49.5M (-$2.96M)

19% less funds holding

Funds holding: 52 → 42 (-10)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

56% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 18

65% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 20

Holders
42
Holders Change
-10
Holders Change %
-19.23%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
7
Reduced
20
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
+$6.41M
2
KCM
Kynam Capital Management
New Jersey
+$1.57M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$150K
4
Goldman Sachs
Goldman Sachs
New York
+$126K
5
HF
HRT Financial
New York
+$53.8K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.44M
2
Millennium Management
Millennium Management
New York
-$595K
3
State Street
State Street
Massachusetts
-$571K
4
Barclays
Barclays
United Kingdom
-$521K
5
DC
Diametric Capital
Massachusetts
-$519K
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
26
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$84.4K – – –
TD Asset Management
27
TD Asset Management
Ontario, Canada
$75.6K – – –
PCM
28
Prelude Capital Management
New York
$73.8K -$202K -8,863 -73%
VIA
29
Vident Investment Advisory
Georgia
$65.7K +$5K +219 +8%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$65.1K -$19.7K -863 -23%
HF
31
HRT Financial
New York
$53K +$53.8K +2,360 New
BFM
32
Boothbay Fund Management
New York
$44.8K +$45.4K +1,990 New
Geode Capital Management
33
Geode Capital Management
Massachusetts
$41K -$20K -876 -32%
YIH
34
Y-Intercept (HK)
Hong Kong
$39K +$13.2K +577 +50%
CC
35
Cannell Capital
Wyoming
$36.5K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$28K +$15.9K +698 +129%
SAM
37
Storebrand Asset Management
Norway
$15.2K – – –
UBS Group
38
UBS Group
Switzerland
$4.22K +$4.26K +187 New
SNN
39
Shen Neil Nanpeng
$1.99K – – –
SOW
40
State of Wyoming
Wyoming
$475 +$342 +15 +250%
Dimensional Fund Advisors
41
Dimensional Fund Advisors
Texas
$137 -$3.15K -138 -2%
O
42
OrbiMed
New York
– -$3.07K -128,282 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
43
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$497K -20,780 Closed
Vanguard Group
44
Vanguard Group
Pennsylvania
– -$396K -16,622 Closed
Marshall Wace
45
Marshall Wace
United Kingdom
– -$305K -12,819 Closed
N
46
Nuveen
North Carolina
– -$124K -5,200 Closed
Squarepoint
47
Squarepoint
New York
– -$122K -5,103 Closed
GCP
48
GSA Capital Partners
United Kingdom
– -$118K -4,956 Closed
Wellington Management Group
49
Wellington Management Group
Massachusetts
– -$115K -4,818 Closed
CSS
50
Cubist Systematic Strategies
Connecticut
– -$67K -2,805 Closed
1
2
3

BNR Hedge Fund Activity: Q4 2022 in Review

42 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q4 2022, worth a combined $49.5M — down 5.6% from $52.5M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of BNR and 8 opened new positions — a net loss of 10 holders — while 20 trimmed existing stakes and 7 added.

The largest buyer was Fidelity International, opening a new position worth an estimated $6.41M. The largest seller was BlackRock, cutting an estimated $3.44M.

  • 42 institutional investors held Burning Rock Biotech (BNR) as of Q4 2022, down from 52 in Q3 2022.
  • Funds reported $49.5M of Burning Rock Biotech stock for Q4 2022, down 5.6% quarter-over-quarter.
  • 8 funds opened new Burning Rock Biotech positions in Q4 2022 and 18 closed out, a net change of -10 holders.
  • The largest Burning Rock Biotech buyer in Q4 2022 was Fidelity International, an estimated $6.41M added.
  • The largest Burning Rock Biotech seller in Q4 2022 was BlackRock, an estimated $3.44M sold.

Based on aggregated 13F filings for Q4 2022.